Results 161 to 170 of about 128,554 (226)

Diagnostic dilemmas in abdominal wall tumors: surgical implications and use of mesh for primary repair: case series. [PDF]

J Surg Case Rep
Dávila DLT, Ochoa CVM, Flores MSM, Reyes GAO, Garcia EDM, Salas DIN, López FIZ, Santamaria CPJ.   +7 more
europepmc   +1 more source

Studies on nanoprotein vaccine alleviating symptoms of mice allergic to rFel d 1. [PDF]

Front Immunol
Mai Y, Sun X, Liu X, Chen H, Liang X, Huang Y, Wu X, Wei S, Wang D, Pei Y.   +9 more
europepmc   +1 more source

Development of a novel multi-epitope peptide vaccine candidate against <i>Mycobacterium tuberculosis</i> using reverse vaccinology. [PDF]

Narra J
Hasan NA, Giri-Rachman EA, Nugrahapraja H.   +2 more
europepmc   +1 more source

Dios Padre

Mayéutica, 1998
openaire   +1 more source

Rib remodeling as a thoracic feminization strategy in transfeminine patients: Case report. [PDF]

JPRAS Open
González-Arestizábal T, Kohnenkampf R, Domínguez C.   +2 more
europepmc   +1 more source

Protective effects of green tea (Camellia sinensis (L.) Kuntze) against kidney diseases: a narrative review. [PDF]

J Bras Nefrol
Ayusso LL, Girol AP, Ayusso Neto L, Gomes I, Burdmann EA.   +4 more
europepmc   +1 more source

Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccine. [PDF]

Sci Transl Med
Akahata W, Komori M, Morey AL, Quiñones-Molina AA, Hood JB, Fofana J, Romero L, Peters E, Webber JD, Meeks T, Przygonska PA, Steinberg I, Ober E, Kim T, Rogan DC, Matsuda K, Smith JF, Gummuluru S, Connors M, Akiyama H.   +19 more
europepmc   +1 more source

Comment on: Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety. [PDF]

Ther Adv Gastroenterol
Borrás-Blasco J, Valcuende-Rosique A, Cornejo-Uixeda S.   +2 more
europepmc   +1 more source

Comadre padre.

The Western journal of medicine, 2010
openaire   +1 more source

Sleep epidemic in the Philippines: A silent driver of cardiovascular risk. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Rogayan DV, Padre EM.
europepmc   +1 more source